| Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion K Tateishi, H Wakimoto, AJ Iafrate, S Tanaka, F Loebel, N Lelic, ... Cancer cell 28 (6), 773-784, 2015 | 413 | 2015 |
| Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss H Arita, Y Narita, S Fukushima, K Tateishi, Y Matsushita, A Yoshida, ... Acta neuropathologica 126, 267-276, 2013 | 401 | 2013 |
| Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma SK McBrayer, JR Mayers, GJ DiNatale, DD Shi, J Khanal, AA Chakraborty, ... Cell 175 (1), 101-116. e25, 2018 | 281 | 2018 |
| Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas T Nakamura, K Tateishi, T Niwa, Y Matsushita, K Tamura, M Kinoshita, ... Neuropathology and applied neurobiology 42 (3), 279-290, 2016 | 210 | 2016 |
| Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas H Wakimoto, S Tanaka, WT Curry, F Loebel, D Zhao, K Tateishi, J Chen, ... Clinical cancer research 20 (11), 2898-2909, 2014 | 196 | 2014 |
| Myc-driven glycolysis is a therapeutic target in glioblastoma K Tateishi, AJ Iafrate, Q Ho, WT Curry, TT Batchelor, KT Flaherty, ... Clinical Cancer Research 22 (17), 4452-4465, 2016 | 144 | 2016 |
| The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity K Tateishi, F Higuchi, JJ Miller, MVA Koerner, N Lelic, GM Shankar, ... Cancer research 77 (15), 4102-4115, 2017 | 94 | 2017 |
| Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with … K Tateishi, U Tateishi, M Sato, S Yamanaka, H Kanno, H Murata, T Inoue, ... American Journal of Neuroradiology 34 (1), 92-99, 2013 | 76 | 2013 |
| Cell surface notch ligand dll3 is a therapeutic target in isocitrate dehydrogenase–mutant glioma M Spino, SC Kurz, L Chiriboga, J Serrano, B Zeck, N Sen, S Patel, G Shen, ... Clinical Cancer Research 25 (4), 1261-1271, 2019 | 56 | 2019 |
| Genotype-targeted local therapy of glioma GM Shankar, AR Kirtane, JJ Miller, H Mazdiyasni, J Rogner, T Tai, ... Proceedings of the National Academy of Sciences 115 (36), E8388-E8394, 2018 | 50 | 2018 |
| Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells H Nagashima, CK Lee, K Tateishi, F Higuchi, M Subramanian, S Rafferty, ... Cancer discovery 10 (11), 1672-1689, 2020 | 42 | 2020 |
| PI3K/AKT/mTOR pathway alterations promote malignant progression and xenograft formation in oligodendroglial tumors K Tateishi, T Nakamura, TA Juratli, EA Williams, Y Matsushita, S Miyake, ... Clinical Cancer Research 25 (14), 4375-4387, 2019 | 40 | 2019 |
| IDH1 mutation and World Health Organization 2016 diagnostic criteria for adult diffuse gliomas: advances in surgical strategy K Tateishi, H Wakimoto, DP Cahill Neurosurgery 64 (CN_suppl_1), 134-138, 2017 | 36 | 2017 |
| Fine-tuning approach for segmentation of gliomas in brain magnetic resonance images with a machine learning method to normalize image differences among facilities S Takahashi, M Takahashi, M Kinoshita, M Miyake, R Kawaguchi, ... Cancers 13 (6), 1415, 2021 | 34 | 2021 |
| Bow Hunter's syndrome by nondominant vertebral artery compression: a case report, literature review, and significance of downbeat nystagmus as the diagnostic clue Y Iida, H Murata, K Johkura, T Higashida, T Tanaka, K Tateishi World Neurosurgery 111, 367-372, 2018 | 29 | 2018 |
| Tumor hypoxia and microscopic diffusion capacity in brain tumors: A comparison of 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET/CT and diffusion … A Hino-Shishikura, U Tateishi, H Shibata, T Yoneyama, T Nishii, I Torii, ... European journal of nuclear medicine and molecular imaging 41, 1419-1427, 2014 | 28 | 2014 |
| A hyperactive RelA/p65-hexokinase 2 signaling axis drives primary central nervous system lymphoma K Tateishi, Y Miyake, M Kawazu, N Sasaki, T Nakamura, J Sasame, ... Cancer Research 80 (23), 5330-5343, 2020 | 26 | 2020 |
| Occipitocervical fusion with relief of odontoid invagination: atlantoaxial distraction method using cylindrical titanium cage for basilar invagination—case report T Yoshizumi, H Murata, Y Ikenishi, M Sato, H Takase, K Tateishi, ... Neurosurgical review 37, 519-525, 2014 | 24 | 2014 |
| Molecular genetics and therapeutic targets of pediatric low-grade gliomas K Tateishi, T Nakamura, T Yamamoto Brain Tumor Pathology 36, 74-83, 2019 | 23 | 2019 |
| Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma T Nakamura, S Yamashita, K Fukumura, J Nakabayashi, K Tanaka, ... Acta neuropathologica 133, 321-324, 2017 | 23 | 2017 |
